Status:
RECRUITING
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cigarette Smoking-Related Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial compares a new smoking cessation smartphone application (app) (iCanQuit) to an existing smarphone app (National Cancer Institute \[NCI\] QuitGuide) for helping American Indians and...
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiv...
Eligibility Criteria
Inclusion
- Self-identify as American Indian or Alaska Native, either alone or in combination with other races
- Age 18 and older
- Has smoked daily for the past year
- Interest in quitting smoking within the next 30 days
- Willing to be randomly assigned to either app
- Have daily access to their own Android or iPhone
- Able to download a smartphone app
- Be willing and able to read English
- Not currently or within past 30 days using other smoking cessation behavioral interventions or smoking cessation pharmacotherapies
- Have never participated in our prior research
- Have no other household or family member participating
- Being willing to complete the 3, 6, and 12-month follow-up assessments
- Providing email, phone number(s), and mailing address
- Living off United States (US) AIAN tribal reservations or living on five Northern Plains tribal reservations from whom we would obtain approvals to recruit
Exclusion
- Currently (i.e., within past 30 days) using other smoking cessation behavioral interventions
- Has participated in our prior research trials
- Has used the National Cancer Institute's (NCI's) QuitGuide app
- Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
- Not providing email, phone number(s), and mailing address
Key Trial Info
Start Date :
July 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2028
Estimated Enrollment :
776 Patients enrolled
Trial Details
Trial ID
NCT06145763
Start Date
July 3 2025
End Date
November 30 2028
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109